Showing results (151-160 of 181) with videos related to

Sort By:
Pageof 19
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 29, 2014
Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trialMarc A Riedl, Jonathan A Bernstein, Henry Li, et al.
Medicina (Kaunas, Lithuania)|May 25, 2024
A Nationwide Study of the Delayed Diagnosis and the Clinical Manifestations of Predominantly Antibody Deficiencies and CTLA4-Mediated Immune Dysregulation Syndrome in GreeceAndroniki Kapousouzi, Fani Kalala, Styliani Sarrou, et al.
Clinical and Translational Allergy|October 19, 2017
An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extensionMarc A Riedl, Jonathan A Bernstein, Timothy Craig, et al.
Frontiers in Allergy|August 4, 2026
Hereditary angioedema care across selected health systems in the Balkan Peninsula area: policy gaps, practice variation, and actionable recommendationsGeorge N Konstantinou, Sladjana Andrejevic, Natasha Angjeleska, et al.
Frontiers in Immunology|August 8, 2018
Secreted Phospholipases A2 in Hereditary Angioedema With C1-Inhibitor DeficiencyStefania Loffredo, Anne Lise Ferrara, Maria Bova, et al.
Lancet (London, England)|July 30, 2017
Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trialMarc A Riedl, Vesna Grivcheva-Panovska, Dumitru Moldovan, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|September 6, 2019
Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled randomized studyH Henry Li, Bruce Zuraw, Hilary J Longhurst, et al.
Allergy|December 21, 2019
Impaired control of the contact system in hereditary angioedema with normal C1-inhibitorMaria Bova, Chiara Suffritti, Valeria Bafunno, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 13, 2018
Population pharmacokinetics of subcutaneous C1-inhibitor for prevention of attacks in patients with hereditary angioedemaDipti Pawaskar, Michael A Tortorici, Bruce Zuraw, et al.
Orphanet Journal of Rare Diseases|July 15, 2018
Emotional processes and stress in children affected by hereditary angioedema with C1-inhibitor deficiency: a multicenter, prospective studyLivia Savarese, Maria Bova, Raffaella De Falco, et al.
Pageof 19